Moreover, miR-204 acts as a tumor suppressor in the metastasis of CC by directly targetting Ephrin type B receptor 2 (EphB2), which might promote the progression of tumors by inducing EMT and affecting its major downstream signaling pathway, PI3K/AKT [136]. Here, AKT1 is linked to neoplasm.